Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma.

Molecular imaging - 1 Jan 2000

Shastry Manu, Miles Kenneth A, Win Thida, Janes Sam M, Endozo Raymond, Meagher Marie, Ell Peter J, Groves Ashley M

Abstract excerpt

We applied modern molecular and functional imaging to the pretreatment assessment of lung cancer using combined dynamic contrast-enhanced computed tomography (DCE-CT) and (18)F-fluorodeoxyglucose-positron emission tomography ((18)F-FDG-PET) to phenotype tumors. Seventy-four lung cancer patients were prospectively recruited for (18)F-FDG-PET/DCE-CT using PET/64-detector CT. After technical failures, there were 64...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorodeoxyglucose F18
Share to Molecular Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multimodal Imaging

Share to Neoplasm Staging

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Share to Statistics, Nonparametric

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 22954179
PMCID: PMC4210517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma.PMID 22954179Read ↗

Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer.Semantic proximity Read ↗

Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer.Semantic proximity Read ↗

Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT.Semantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.Semantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutationsSemantic proximity Read ↗

Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

PET Imaging of Metabolism, Perfusion, and HypoxiaSemantic proximity Read ↗

Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.Semantic proximity Read ↗

Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.Semantic proximity Read ↗

A Nomogram for the Prediction of Invasiveness in Invasive Pulmonary Adenocarcinoma on the Basis of Multimodal PET/CT Parameters.Semantic proximity Read ↗

The FAP-FDG Integration Score (FFIS): Development and prognostic validation of a dual-tracer PET phenotype for solid tumors.Semantic proximity Read ↗

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.